InvestorsHub Logo
Followers 61
Posts 7553
Boards Moderated 2
Alias Born 02/10/2010

Re: Its_lose_not_loose post# 123801

Thursday, 08/25/2016 9:55:41 AM

Thursday, August 25, 2016 9:55:41 AM

Post# of 146291
This statement is hardly new,.... they have had language in the last few quarterly reports talking about anti-Zika/Dengue drugs and work that can be done on them.

They also (previously) have announced the employment of Dr. Friedrich,... the presence of the BSL-2 room(s),... and that doing such work (optimizing ligands and cell-culture assays in-house for example) is a large part of what they expected Dr. Friedrich to bring to the table,...

What is the FOTM point here? As the Company hasn't specifically stated that they are moving this forward,...

And as soon as the HerpesCide is out the door, and as soon as the FluCide TOX can get restarted,....

Why not have an anti-Flavivirius compound or two ready to push next into the pipeline?

So - can I interpret the statement made here as suggesting that NO R&D work on small scale should be going on at all?

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News